AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies
Clinical trial NCT00463814 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00463814
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-08
- Primary completion
- 2008-06-17
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.